China Pharma Holdings (CPHI) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $33.0 million.
- China Pharma Holdings' Accumulated Depreciation & Amortization rose 110.0% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.0 million, marking a year-over-year increase of 110.0%. This contributed to the annual value of $32.1 million for FY2024, which is 560.54% up from last year.
- As of Q3 2025, China Pharma Holdings' Accumulated Depreciation & Amortization stood at $33.0 million, which was up 110.0% from $32.6 million recorded in Q2 2025.
- In the past 5 years, China Pharma Holdings' Accumulated Depreciation & Amortization registered a high of $33.0 million during Q3 2025, and its lowest value of $26.1 million during Q2 2021.
- For the 5-year period, China Pharma Holdings' Accumulated Depreciation & Amortization averaged around $29.8 million, with its median value being $29.4 million (2023).
- Per our database at Business Quant, China Pharma Holdings' Accumulated Depreciation & Amortization surged by 2276.97% in 2021 and then surged by 68.1% in 2022.
- Over the past 5 years, China Pharma Holdings' Accumulated Depreciation & Amortization (Quarter) stood at $28.2 million in 2021, then increased by 0.68% to $28.4 million in 2022, then rose by 7.21% to $30.4 million in 2023, then rose by 5.61% to $32.1 million in 2024, then increased by 2.72% to $33.0 million in 2025.
- Its last three reported values are $33.0 million in Q3 2025, $32.6 million for Q2 2025, and $32.3 million during Q1 2025.